Skip to main content
SpringerLink
Log in

Consider adverse effects and pharmacological interactions when treating depression in HIV-positive patients

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Pieper AA, Treisman GJ. Drug treatment of depression in HIV-positive patients: safety considerations. Drug Saf 2005; 28(9): 753–62

    Article  PubMed  CAS  Google Scholar 

  2. Bing EG, Burnam MA, Longshort E, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001; 58: 721–8

    Article  PubMed  CAS  Google Scholar 

  3. Grassi B, Gambini O, Garghentini G, et al. Efficacy of paroxetine for the treatment of depression in the context of HIV infection. Pharmacopsychiatry 1997; 30(2): 70–1

    Article  PubMed  CAS  Google Scholar 

  4. Cazzullo CL, Bessone E, Bertrando P, et al. Treatment of depression in HIV-infected patients. J Psychiatry Neurosci 1998; 23(5): 293–7

    PubMed  CAS  Google Scholar 

  5. Rabkin JG, Rabkin R, Harrison W, et al. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness. Am J Psychiatry 1994; 151: 516–23

    PubMed  CAS  Google Scholar 

  6. Treisman G, Fishman M, Lyketsos C, et al. Evaluation and treatment of psychiatric disorders associated with HIV infection. Res Publ Assoc Res Nerv Ment Dis 1994; 72: 239–50

    PubMed  CAS  Google Scholar 

  7. Lyketsos CG, Treisman GJ. Psychiatric disorders in HIV-infected patients. CNS Drugs 1995; 4: 195–206

    Article  Google Scholar 

  8. De Wit S, Cremers L, Hirsch D, et al. Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study. J Int Med Res 1999; 27(5): 223–32

    Google Scholar 

  9. Park-Wyllie LY, Antoniou T. Concurrent use of bupropion with CYP2B6 inhibitors, nelfinavir, ritonavir and efavirenz: a case series. AIDS 2003; 17: 638–40

    Article  PubMed  Google Scholar 

  10. Treisman GJ, Kaplin AI. Neurologic and psychiatric complications of antiretroviral agents. AIDS 2003; 16: 1201–15

    Article  Google Scholar 

  11. Dresser GK, Spence JD, Bailey DG. Pharmocokinetic-pharmaco-dynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet 2000; 38(1): 41–57

    Article  PubMed  CAS  Google Scholar 

  12. Ouellet D, Hsu A, Qian J, et al. Effect of fluoxetine on pharmacokinetics of ritonavir. Antimicrob Agents Chemother 1998; 42(12): 3107–12

    PubMed  CAS  Google Scholar 

  13. Hesse LM, von Moltke LL, Shader RI, et al. Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion. Drug Metab Dispos 2001; 29: 100–2

    PubMed  CAS  Google Scholar 

  14. Greenblatt DJ, von Moltke LL, Harmatz JS, et al. Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone. J Clin Pharmacol 2003; 43(4): 414–22

    Article  PubMed  CAS  Google Scholar 

  15. Grassi B, Gambini O, Garghentini G, et al. Efficacy of paroxetine for the treatment of depression in the context of HIV infection. Pharmacopsychiatry 1997; 30(2): 70–1

    Article  PubMed  CAS  Google Scholar 

  16. Treisman GJ, Angelino AF. ia]The Psychiatry of AIDS: a guide to diagnosis and treatment. Chapter 2: HIV and major depression. Baltimore (MD): The Johns Hopkins University Press, 2004

  17. Zisook S, Peterkin J, Goggin KJ, et al. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group. J Clin Psychiatry 1998; 59(5): 217–24

    Article  PubMed  CAS  Google Scholar 

  18. Rothschild AJ. New directions in the treatment of antidepressant-induced sexual dysfunction. Clin Ther 2000; 22 Suppl. A: A42–A51; discussion A58-61

    Article  PubMed  CAS  Google Scholar 

  19. DeSilva KE, LeFlore DB, Marston BJ, et al. Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine. AIDS 2001; 15: 1281–5

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Consider adverse effects and pharmacological interactions when treating depression in HIV-positive patients. Drugs Ther. Perspect 22, 9–11 (2006). https://doi.org/10.2165/00042310-200622060-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200622060-00003

Search

Navigation